News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,970 Results
Type
Article (14312)
Company Profile (101)
Press Release (260548)
Multimedia
Podcasts (66)
Webinars (13)
Section
Business (88320)
Career Advice (466)
Deals (15397)
Drug Delivery (75)
Drug Development (36729)
Employer Resources (50)
FDA (6390)
Job Trends (6235)
News (150774)
Policy (14133)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (443)
Accelerated approval (15)
Adcomms (8)
Allergies (81)
Alliances (23319)
ALS (61)
Alzheimer's disease (487)
Antibody-drug conjugate (ADC) (109)
Approvals (6604)
Artificial intelligence (215)
Autoimmune disease (54)
Automation (15)
Bankruptcy (150)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (125)
Biotechnology (39)
Bladder cancer (41)
Brain cancer (33)
Breast cancer (182)
Cancer (1411)
Cardiovascular disease (165)
Career advice (419)
Career pathing (13)
CAR-T (52)
CDC (6)
Cell therapy (163)
Cervical cancer (12)
Clinical research (32148)
Collaboration (788)
Compensation (342)
Complete response letters (38)
COVID-19 (781)
CRISPR (46)
C-suite (491)
Cystic fibrosis (59)
Data (1974)
Denatured (18)
Depression (51)
Diabetes (131)
Diagnostics (1402)
Digital health (10)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (130)
Drug pricing (115)
Drug shortages (12)
Duchenne muscular dystrophy (89)
Earnings (33733)
Editorial (22)
Employer branding (4)
Employer resources (46)
Events (39223)
Executive appointments (556)
FDA (7558)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (464)
Gene editing (75)
Generative AI (19)
Gene therapy (178)
GLP-1 (450)
Government (1413)
Grass and pollen (4)
Guidances (166)
Healthcare (3586)
HIV (14)
Huntington's disease (9)
IgA nephropathy (42)
Immunology and inflammation (72)
Immuno-oncology (16)
Indications (66)
Infectious disease (858)
Inflammatory bowel disease (82)
Inflation Reduction Act (7)
Influenza (26)
Intellectual property (118)
Interviews (60)
IPO (5914)
IRA (33)
Job creations (2057)
Job search strategy (374)
JPM (29)
Kidney cancer (10)
Labor market (29)
Layoffs (206)
Leadership (8)
Legal (3449)
Liver cancer (23)
Longevity (8)
Lung cancer (191)
Lymphoma (132)
Machine learning (13)
Management (17)
Manufacturing (447)
MASH (75)
Medical device (1307)
Medtech (1316)
Mergers & acquisitions (9924)
Metabolic disorders (470)
mRNA (53)
Multiple sclerosis (52)
NASH (14)
Neurodegenerative disease (91)
Neuropsychiatric disorders (40)
Neuroscience (930)
Neurotech (1)
NextGen: Class of 2026 (1589)
Non-profit (605)
Now hiring (20)
Obesity (247)
Opinion (145)
Ovarian cancer (41)
Pain (118)
Pancreatic cancer (55)
Parkinson's disease (88)
Partnered (11)
Patents (237)
Patient recruitment (131)
Peanut (14)
People (29877)
Pharmaceutical (60)
Pharmacy benefit managers (18)
Phase 1 (8335)
Phase 2 (13573)
Phase 3 (12262)
Pipeline (2328)
Policy (142)
Postmarket research (1402)
Preclinical (3353)
Press Release (25)
Prostate cancer (92)
Psychedelics (17)
Radiopharmaceuticals (138)
Rare diseases (389)
Real estate (2659)
Recruiting (19)
Regulatory (11064)
Reports (15)
Research institute (580)
Resumes & cover letters (56)
Rett syndrome (6)
RNA editing (6)
RSV (21)
Schizophrenia (73)
Series A (89)
Series B (54)
Service/supplier (2)
Sickle cell disease (48)
Special edition (10)
Spinal muscular atrophy (82)
Sponsored (9)
Startups (1649)
State (2)
Stomach cancer (6)
Supply chain (52)
Tariffs (68)
The Weekly (46)
Vaccines (242)
Venture capital (33)
Weight loss (146)
Women's health (33)
Worklife (4)
Date
Last 7 days (200)
Last 30 days (899)
Last 365 days (10320)
2026 (2060)
2025 (10721)
2024 (12500)
2023 (14247)
2022 (19565)
2021 (20081)
2020 (19034)
2019 (14889)
2018 (11713)
2017 (13892)
2016 (13134)
2015 (15476)
2014 (12419)
2013 (10593)
2012 (11395)
2011 (11924)
2010 (10890)
Location
Africa (318)
Alabama (19)
Alaska (1)
Arizona (79)
Arkansas (4)
Asia (20969)
Australia (2696)
California (3387)
Canada (1561)
China (586)
Colorado (149)
Connecticut (136)
Delaware (130)
Europe (41086)
Florida (642)
Georgia (66)
Hawaii (1)
Idaho (10)
Illinois (373)
India (48)
Indiana (257)
Iowa (2)
Japan (271)
Kansas (78)
Kentucky (21)
Louisiana (4)
Maine (2)
Maryland (447)
Massachusetts (2754)
Michigan (47)
Minnesota (177)
Mississippi (1)
Missouri (35)
Montana (9)
Nebraska (8)
Nevada (17)
New Hampshire (8)
New Jersey (1497)
New Mexico (7)
New York (966)
North Carolina (649)
North Dakota (2)
Northern California (1554)
Ohio (83)
Oklahoma (5)
Oregon (18)
Pennsylvania (759)
Puerto Rico (13)
Rhode Island (18)
South America (508)
South Carolina (10)
Southern California (1489)
Tennessee (56)
Texas (481)
United States (13471)
Utah (63)
Virginia (175)
Washington D.C. (42)
Washington State (237)
West Virginia (1)
Wisconsin (40)
Wyoming (1)
274,970 Results for "eton pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
February 2, 2026
·
3 min read
Press Releases
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
February 26, 2026
·
9 min read
Press Releases
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
February 20, 2026
·
1 min read
Press Releases
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
March 4, 2026
·
1 min read
Press Releases
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
March 2, 2026
·
7 min read
Press Releases
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results
November 6, 2025
·
24 min read
Press Releases
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th
November 25, 2025
·
1 min read
Press Releases
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
November 13, 2025
·
1 min read
Press Releases
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
October 23, 2025
·
1 min read
Press Releases
Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference
August 20, 2025
·
1 min read
1 of 27,497
Next
